These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16802855)

  • 41. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
    Saari TI; Grönlund J; Hagelberg NM; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2010 Apr; 66(4):387-97. PubMed ID: 20076952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
    Darwish M; Xie F
    Pain Pract; 2012 Apr; 12(4):307-14. PubMed ID: 21831253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
    Heiskanen T; Olkkola KT; Kalso E
    Clin Pharmacol Ther; 1998 Dec; 64(6):603-11. PubMed ID: 9871425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.
    Leuppi-Taegtmeyer A; Duthaler U; Hammann F; Schmid Y; Dickenmann M; Amico P; Jehle AW; Kalbermatter S; Lenherr C; Meyer Zu Schwabedissen HE; Haschke M; Liechti ME; Krähenbühl S
    Nephrol Dial Transplant; 2019 Apr; 34(4):692-702. PubMed ID: 30189012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation.
    Tallgren M; Olkkola KT; Seppälä T; Höckerstedt K; Lindgren L
    Clin Pharmacol Ther; 1997 Jun; 61(6):655-61. PubMed ID: 9209248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of Oxycodone.
    Piirainen A; Kokki H; Immonen S; Eskelinen M; Häkkinen MR; Hautajärvi H; Kokki M
    Drugs R D; 2015 Dec; 15(4):319-28. PubMed ID: 26364041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
    Stamer UM; Zhang L; Book M; Lehmann LE; Stuber F; Musshoff F
    PLoS One; 2013; 8(3):e60239. PubMed ID: 23555934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years--a pilot study.
    Payne KA; Roelofse JA; Shipton EA
    Anesth Prog; 2002; 49(4):109-12. PubMed ID: 12779111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
    Franke RM; Morton T; Devarakonda K
    Drug Des Devel Ther; 2015; 9():4587-97. PubMed ID: 26316698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
    Schaff EA; DiCenzo R; Fielding SL
    Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal interaction between gatifloxacin and oxycodone.
    Grant EM; Nicolau DR; Nightingale C; Quintiliani R
    J Clin Pharmacol; 2002 Aug; 42(8):928-32. PubMed ID: 12162476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
    Balyan R; Mecoli M; Venkatasubramanian R; Chidambaran V; Kamos N; Clay S; Moore DL; Mavi J; Glover CD; Szmuk P; Vinks A; Sadhasivam S
    Pharmacogenomics; 2017 Mar; 18(4):337-348. PubMed ID: 28244808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
    Leibowitz MT; Zamora CA; Brzeczko AW; Stark JG
    Am J Ther; 2014; 21(2):99-105. PubMed ID: 22357166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    J Pharm Sci; 2005 May; 94(5):1060-6. PubMed ID: 15799017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the pharmacokinetics of oxycodone administered in three Percocet formulations.
    Gammaitoni AR; Davis MW
    J Clin Pharmacol; 2002 Feb; 42(2):192-7. PubMed ID: 11831542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
    Samolsky Dekel BG; Donati G; Vasarri A; Croci Chiocchini AL; Gori A; Cavallari G; Di Nino G; Mercolini L; Protti M; Mandrioli R; Melotti RM; La Manna G
    Pain Pract; 2017 Jun; 17(5):604-615. PubMed ID: 27589376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central nervous system penetration of oxycodone after intravenous and epidural administration.
    Kokki M; Välitalo P; Kuusisto M; Ranta VP; Raatikainen K; Hautajärvi H; Kokki H
    Br J Anaesth; 2014 Jan; 112(1):133-40. PubMed ID: 24131664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone.
    Naito T; Takashina Y; Yamamoto K; Tashiro M; Ohnishi K; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2011 Nov; 51(11):1529-38. PubMed ID: 21209234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.